Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0WF7L
|
||||
| Former ID |
DCL000499
|
||||
| Drug Name |
Brilinta
|
||||
| Synonyms |
Brilique; Ticagrelor; AR-C126532; AZD-6140; Ticagrelor (USAN/INN)
|
||||
| Drug Type |
Small molecular drug
|
||||
| Company |
AstraZeneca
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C23H28F2N6O4S
|
||||
| InChI |
InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1
|
||||
| InChIKey |
OEKWJQXRCDYSHL-FNOIDJSQSA-N
|
||||
| CAS Number |
CAS 274693-27-5
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
14836432, 14860737, 24162024, 45293678, 49684205, 57373617, 77877844, 92729712, 96025700, 103554312, 123051091, 124759706, 126644885, 126666051, 135649975, 136345665, 137171656, 139857160, 152040158, 152258075, 160645837, 160646914, 162011636, 163346229, 163383616, 164178089, 164765598, 165245536, 170501033, 171063069, 172914585, 174528632, 175267325, 175427101, 185974765, 189657701, 198993342, 211534943, 223384813, 223666650, 224638556, 228139491, 247988848, 249582784, 249807649, 249807650, 249816423, 251966736, 251970939, 252216468
|
||||
| SuperDrug ATC ID |
B01AC24
|
||||
| Target and Pathway | |||||
| Target(s) | P2Y purinoceptor 12 | Target Info | Antagonist | [550288] | |
| KEGG Pathway | Platelet activation | ||||
| References | |||||
| Ref 531783 | 2011 FDA drug approvals. Nat Rev Drug Discov. 2012 Feb 1;11(2):91-4. | ||||
| Ref 539115 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1765). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.